Bausch Health
BHC
234 hedge funds and large institutions have $1.96B invested in Bausch Health in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 76 reducing their positions, and 37 closing their positions.
3% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 37
1.07% less ownership
Funds ownership: 77.72% → 76.65% (-1.1%)
1% less funds holding
Funds holding: 237 → 234 (-3)
25% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 76
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
34% less capital invested
Capital invested by funds: $2.96B → $1.96B (-$997M)
72% less call options, than puts
Call options by funds: $34.3M | Put options by funds: $124M
Top Buyers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$30.3M |
| 2 |
Goldman Sachs
New York
|
+$25.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$24.4M |
| 4 |
PC
PointState Capital
New York
|
+$11.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$11.1M |
Top Sellers
| 1 |
GAM
Goldentree Asset Management
New York
|
-$39.4M |
| 2 |
N
Natixis
Paris,
France
|
-$38.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$33.7M |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$22.3M |
| 5 |
Morgan Stanley
New York
|
-$12M |
BHC Hedge Fund Activity: Q2 2024 in Review
234 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2024, worth a combined $1.96B — down 34% from $2.96B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new BHC positions and 37 closed out — a net gain of 1 holder — while 57 added to existing stakes and 76 trimmed.
The largest buyer was Nomura Holdings, adding an estimated $30.3M. The largest seller was Goldentree Asset Management, cutting an estimated $39.4M.
- 234 institutional investors held Bausch Health (BHC) as of Q2 2024, down from 237 in Q1 2024.
- Funds reported $1.96B of Bausch Health stock for Q2 2024, down 34% quarter-over-quarter.
- 38 funds opened new Bausch Health positions in Q2 2024 and 37 closed out, a net change of +1 holder.
- The largest Bausch Health buyer in Q2 2024 was Nomura Holdings, an estimated $30.3M added.
- The largest Bausch Health seller in Q2 2024 was Goldentree Asset Management, an estimated $39.4M sold.
Based on aggregated 13F filings for Q2 2024.